TITLE

Clinical trials: the balance between protecting participants and promoting drug and product development

AUTHOR(S)
Shuchman, Miriam
PUB. DATE
March 2009
SOURCE
CMAJ: Canadian Medical Association Journal;3/17/2009, Vol. 180 Issue 6, p603
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the strategies that need to be considered by the health industry in Canada which will help enhance the conduct of reviews on clinical trials by research ethics boards in the country. These include the development of accreditation standards for research ethics boards by the Sponsors' Table for Human Research Participant Protection, implementing revisions to its Tri-Council Policy Statement, and building cooperation between health associations and committees in the development of an efficient research review system. It reveals that the strategies will play essential role in achieving success in clinical trials and the delivery of drugs to customers.
ACCESSION #
36872506

 

Related Articles

  • The rights of patients in research. Goodare, Heather; Smith, Richard // BMJ: British Medical Journal (International Edition);5/20/95, Vol. 310 Issue 6990, p1277 

    Discusses the importance of acknowledging the role played by patients in the design, conduct and reporting of clinical research. Sample case of a complementary treatment offered to women with breast cancer by the Bristol Help Centre in England; Ways in which patients and the public can be...

  • Research ethics review: Do it once and do it well. Hébert, Paul; Saginur, Raphael // CMAJ: Canadian Medical Association Journal;3/17/2009, Vol. 180 Issue 6, p597 

    The authors reflect on the strategies that need to be considered by the health industry in Canada which will help enhance research ethics review in the country. They assert that partnership between health associations and committees will play essential role in the development of an efficient...

  • IMPACT OF THE EUROPEAN CLINICAL TRIALS DIRECTIVE ON ACADEMIC CLINICAL RESEARCH. Baeyens, A. J. // Medicine & Law (World Association for Medical Law);2004, Vol. 23 Issue 1, p103 

    With the adoption of the Clinical Trials Directive it was Europe's intention to make the performance of multi-national clinical trials in Europe easier through the harmonization of the regulatory procedures. As the Directive was mainly conceived to facilitate the performance of multi-national...

  • Clinical trial participation poses ethical, practical issues. Silversides, Ann // CMAJ: Canadian Medical Association Journal;3/3/2009, Vol. 180 Issue 5, p500 

    The article reports on the ethical issues involving physicians who recruit patients to participate in clinical trials in Canada. It reveals that ethical concern has emerged concerning the amount of money received by physicians which may result to conflicts of interest as well as challenges the...

  • Creating a National Infrastructure for Good Clinical Practice in Clinical Trials in Ukraine. Kundiiev, Yurii I.; Vitte, Peter N.; Lyzogub, Vyctor G.; Stepanenko, Alla // Pharmaceutical Medicine - New Zealand;2008, Vol. 22 Issue 6, p355 

    This article examines the current Ukrainian approach to creating a national infrastructure for medicines advancement and human subjects protection through clinical trials based on good clinical practice (GCP). It explores the roles of the government, the healthcare society, ethics committees and...

  • Ethics in Clinical Research: The Indian Perspective. Sanmukhani, J.; Tripathi, C. B. // Indian Journal of Pharmaceutical Sciences;Mar/Apr2011, Vol. 73 Issue 2, p125 

    Ethics in clinical research focuses largely on identifying and implementing the acceptable conditions for exposure of some individuals to risks and burdens for the benefit of society at large. Ethical guidelines for clinical research were formulated only after discovery of inhumane behavior with...

  • A Walk in the Park: A Case Study in Research Ethics. Lazzarini, Zita; Case, Patricia; Thomas, Cecil J. // Journal of Law, Medicine & Ethics;Spring2009, Vol. 37 Issue 1, p93 

    Can researchers, interested in novel ways to assess HIV seroprevalence among populations which are otherwise hidden, collect condoms that have been discarded on the ground in a public sex environment and test them for HIV? Researchers, who use other types of abandoned samples, such as discarded...

  • Impact on the Future. Doren, Philip E.; O'Donnell, Teri; Pearson, Jamie // Applied Clinical Trials;Jul/Aug2013, Vol. 22 Issue 7/8, p4 

    The article focuses on the application of Risk-based monitoring (RBM) for making drug development a more effective process while providing high quality results on time and under the budget. It mentions that RBM carefully analyzes the sources that impose meaningful threats to the goals of...

  • Looking for Cures. Gordon, Teresa // Hispanic;Apr2005, Vol. 18 Issue 4, p46 

    Features the National Institutes of Health Clinical Center in Bethesda, Maryland. Reason Hispanics should participate in clinical research; Definition of a clinical trial; Impact of participating on clinical trial on Narcisa Castro of Ecuador who suffer from severe nausea and headaches.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics